HealthQuill
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Pharma

Johnson & Johnson ends late-stage trial of depression drug aticaprant

HQ Team March 7, 2025: Johnson & Johnson is discontinuing the Phase 3 VENTURA clinical trial of its experimental depression drug aticaprant after.

Read More
pollution
Climate

Half of world’s CO2 emissions linked to 36 fossil fuel companies: Report

HQ Times March 7, 2025: A report by Carbon Majors has Coal India listed second among 36 fossil fuel companies responsible for half.

Read More
Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latter’s technology to discover tissue-targeting molecules.
Drugs Medical Pharma

Novo Nordisk to pay US-based Gensaic $354 million upfront in licensing deal

HQ Team March 5, 2025: Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latter’s.

Read More
US scientists have blocked a protein that kills a variety of cancer cells in an experiment on mice, pointing to a new potential target for cancer treatment, according to the National Institutes of Health.
Drugs Health Research

US scientists block proteins that aid cancer cells’ group strategy to survive

HQ Team March 5, 2025: US scientists have blocked a protein that kills a variety of cancer cells in an experiment on mice,.

Read More
In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him ultimate happiness. However, his dream quickly turned into a nightmare when his food—and even his beloved daughter—turned to gold.  Midas became trapped by his irrational desire, blinded by the allure of wealth without considering its consequences.
Health Opinion Research

Curbing the King Midas’ golden touch in you during modern times

By Aparna S March 4, 2025: In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him.

Read More
Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer's disease, and these abnormal proteins also accumulate in the dying cells in the retina of the eyes of the patients with the condition, investigators at Cedars-Sinai Medical Center found.
Health Pharma Research

Abnormal protein accumulation in patient’s eyes linked to Alzheimer’s

HQ Team March 4, 2025: Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer’s disease, and these.

Read More
AbbVie Inc. will license a drug to treat obesity from Denmark’s Gurba A/S, a preclinical contract research services and peptide-based drug discovery, for about $2.2 billion to mark its entry into the obesity treatment space.
Drugs Medical Pharma

AbbVie inks $2.2b deal with Denmark’s Gurba, enters weight-loss market

 HQ Team March 4, 2025: AbbVie Inc. will license a drug to treat obesity from Denmark’s Gurba A/S, a preclinical contract research services.

Read More
Thermo Fisher Scientific to buy Solvemtum’s purification unit for $4.1 billion in cash
Drugs Medical Pharma

Thermo Fisher to buy Solventum’s filtration unit for $4.1 billion in cash

HQ Team March 1, 2025: Thermo Fisher Scientific Inc., will buy Solventum’s purification and filtration business for $4.1 billion in cash to support.

Read More
A school-aged child died following an outbreak of measles in Texas, US, and the number of people infected in the outbreak has gone up to 146, the Texas Department of State Health Services stated.
Drugs Health Medical

Unvaccinated child dies in US, Texas state, due to measles disease

HQ Team March 1, 2025: A school-aged child died following an outbreak of measles in Texas, US, and the number of people infected.

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Health Research

Mid-frontal brain folds key to schizophrenia: Zurich study finds

HQ Team February 27, 2025: The uniformity of brain folding in the mid-frontal area suggests a developmental trait common to people with schizophrenia,.

Read More